Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q3 2024 vs. Q2 2024
How the institutions holding Cidara Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 27 | +2 |
| Shares | 1.42M | 48.5K | 3.31M | +1.94M (+141.9%) |
| Value | $16.9M | $579.2K | $35.6M | +$19.3M (+118.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 703,080 | $7.56M | 0.09% |
| Bain Capital Life Sciences Investors, LLC | 703,080 | $7.56M | 0.79% |
| BlackRock, Inc. | 48,920 | $525.9K | 0.00% |
| Adage Capital Partners GP, L.L.C. | 42,755 | $459.6K | 0.00% |
| Northern Trust Corp | 31,787 | $341.7K | 0.00% |
| Millennium Management LLC | 13,919 | $149.6K | 0.00% |
| Avion Wealth | 250 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Cidara Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| US Bancorp | 13,103 | $156.4K |
| Wetzel Investment Advisors, Inc. | 4,000 | $3.68K |
| Royal Bank of Canada | 67 | $1.00K |
| Northwestern Mutual Wealth Management Co | 14 | $167 |
| Qube Research & Technologies Ltd | 2 | $24 |
Not filed for Q3 2024 yet (1)
Institutions that held Cidara Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 48,512 | $579.2K |